I find fascinating to project how the latest technology and consumer behavior could apply to life science companies companies during their development process
Past News ReleasesRSS
Sunnyvale, CA (PRWEB) June 16, 2015
In an innovative approach, Clinovo CTO Marc Desgrousilliers and CEO Glenn Keet demonstrate how the broad adoption of biosensors by consumers, combined with advances in Nano and Cloud technologies, are expected to radically change the way research is conducted by the Life Science industry.
Published in Clinical Leader, the online media for clinical trial experts, this paper titled “How wearable electronics will change clinical trials”, addresses how wearable technology can improve patient recruiting and monitoring, while lowering development and therapy cost. Read full article in Clinical Leader
“I find fascinating to project how the latest technology and consumer behavior could apply to life science companies companies during their development process”, explains Marc Desgrousilliers, CTO at Clinovo and co-author of the paper. “At Clinovo, we are constantly analyzing how breakthrough technologies can be adopted in clinical trials to reduce development costs, speed up access to treatment, and improve clinical data quality. ”
Abstract - Advances in sensor technology and microelectronics have opened new opportunities in the health and life sciences industries. Wearable sensors allow for continuous bio-monitoring without any manual intervention, thus reducing provider-patient interaction and costs while contributing improvements in the quality of the data. Perhaps the biggest news about the Watch launch is the re-introduction of the Research Kit technology that is expected to transform patient recruitment and data collection. With the Research Kit, iPhone and Apple watch owners will be able to download clinical apps and allow their data to be collected and anonymized.
Clinovo regularly writes papers on various topics on how to streamline the clinical trial process. Clinovo’s papers discuss the latest industry trends and challenges, as well as innovative technologies and best practices to overcome them. One of its latest papers published in labiotech.eu explains how to overcome the cost and complexity of switching from paper to Electronic Data Capture (EDC) systems.